About GSK
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
-
£34bn
turnover in 2020
-
3
global businesses
-
300
years of innovation
What we do
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
Pharmaceuticals

£17bn, +1% CER sales turnover 2020
Our Pharmaceuticals business has a broad portfolio of innovative and established medicines in respiratory, HIV, immuno-inflammation and oncology. We are strengthening our R&D pipeline through a focus on immunology, human genetics and advanced technologies to help us deliver transformational new medicines for patients.
Key products
Trelegy – Asthma/COPD
Nucala – Severe Asthma
Triumeq/Tivicay – HIV
Vaccines

£7bn, +1% CER sales turnover 2020
We are the world’s largest vaccines company by revenue, delivering vaccines that help protect people at all stages of life. Our R&D focuses on developing vaccines against infectious diseases that combine high medical need and strong market potential.
Key products
Shingrix – Shingles
Infanrix – Paediatric
Bexsero – Meningitis
Consumer Healthcare

£10bn, +1% CER sales turnover 2020
Our world-leading Consumer Healthcare business combines science and consumer insights to create innovative everyday healthcare brands that consumers trust and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
On 1 August 2019 we announced that we'd completed our transaction with Pfizer to combine our consumer healthcare businesses into a new world-leading Consumer Healthcare Joint Venture. Within three years of the closing of the transaction, we intend to separate the Joint Venture via a demerger. With our future intention to separate, the transaction also presents a clear pathway forward for us to create a new global Pharmaceuticals/Vaccines company, and a new world-leading Consumer Healthcare company. Find out more
Key products
Sensodyne – Oral health
Voltaren – Pain relief (topical)
Panadol – Pain relief (systemic)
*Reported AER and CER growth rates include five months’ results of former Pfizer consumer healthcare business. Pro-forma CER growth rates are calculated as if the equivalent five months of Pfizer consumer healthcare business results, as reported by Pfizer, were included in the comparative period of 2018.
How we do it
Everyone at GSK is focused on 3 priorities – Innovation, Performance, Trust
Innovation
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.
-
£4.6bn
adjusted R&D investment in 2020
-
40
new medicines in development at FY 2020
-
17
new vaccines in development at FY 2020
Performance
We aim to achieve industry-leading growth by investing effectively in our business, developing our people and delivering flawlessly.
-
£34bn
turnover in 2020
-
£9bn
adjusted operating profit in 2020
-
£5.4bn
free cash flow in 2020
-
£4bn
dividends paid in 2020
Trust
We are a responsible company and commit to use our science and technology to address health needs, make our products affordable and available and to be a modern employer.
-
84%
employee engagement score on our latest employee survey
-
£250m
donated in 2020 to community health programmes
-
1st
in Access to Medicines Index since the assessment began in 2008
Key figures

Please refer to our quarterly results materials for further information on GSK’s financial performance.
Our geographies
-
£14.6bn (43%)
US (+6% CER) sales turnover 2020
-
£8.2bn (24%)
Europe (+1% CER) sales turnover 2020
-
£11.4bn (33%)
International (flat CER) sales turnover 2020

Annual report 2020
Find out more about us
-
Quarterly results
Discover our latest financial performance announcement and search for historical quarterly results materials
-
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
-
Our history
It began when Plough Court Pharmacy was established in 1715. Discover GSK's journey through the centuries that led to the organisation we know today
-
Our pipeline
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and payers